세계의 COVID-19용 곽향정기(Huoxiang Zhengqi) 시장 보고서(2025년)
Huoxiang Zhengqi For Covid 19 Global Market Report 2025
상품코드 : 1760560
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,675,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,648,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,622,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

COVID-19용 곽향정기(Huoxiang Zhengqi) 시장 규모는 향후 몇 년 동안 빠르게 성장할 것으로 예상되며, 2029년에는 12.4%의 CAGR로 24억 8,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 면역 건강보조제의 인기 증가, 경미한 건강 문제에 대한 자가 치료 경향 증가, 비약물적 개입에 대한 수요 증가, 한약 제품의 온라인 접근성 향상, 맞춤형 건강 솔루션에 대한 수요 증가에 기인합니다. 수요 증가에 기인합니다. 예측 기간 동안 예상되는 주요 동향으로는 기술 지원을 통한 원격 진단, 새로운 제형 개발, 시너지 효과가 있는 제형 개발, 원격의료 플랫폼과의 통합, 병원 COVID-19 치료 지침과의 일치 등이 있습니다.

한약에 대한 수요가 증가함에 따라 COVID-19용 곽향정기(Huoxiang Zhengqi) 시장의 성장을 촉진할 것으로 예상됩니다. 중국 전통의학(TCM)은 한약, 침술, 마사지, 식이요법 등을 사용하여 신체의 에너지 균형을 맞추고 치유를 촉진하며 질병을 예방하는 고대 치료 시스템으로, TCM에 대한 수요 증가는 소비자의 대체 요법 추구와 자연 요법 및 전체론적 건강법에 대한 관심의 증가로 인한 것입니다. COVID-19용 곽향정기(Huoxiang Zhengqi)는 면역 체계의 균형을 맞추고 바이러스 감염에 따른 증상을 완화하는 능력으로 알려진 허브 성분을 통합한 치료 솔루션을 제공함으로써 TCM을 강화합니다. 예를 들어, 2025년 1월 국립의학도서관은 약용 재료와 식물 추출물을 포함한 중국 전통 의학의 수출액이 2023년 19억 3,300만 달러에 달할 것이라고 보고했습니다. 그 결과, 한약에 대한 수요 증가가 COVID-19용 곽향정기(Huoxiang Zhengqi) 시장의 성장을 주도하고 있습니다.

한약 수요 증가로 인해 COVID-19용 곽향정기(Huoxiang Zhengqi) 시장의 성장을 촉진할 것으로 예상됩니다. 한약은 식물 또는 식물 유래 물질을 치료 목적으로 사용하여 건강 상태를 예방, 치료, 관리하기 위해 사용하는 것입니다. 한약에 대한 선호도가 높아지는 것은 주로 자연 요법에 대한 소비자의 관심으로 인해 합성 의약품에 비해 안전하고, 부작용이 적으며, 다른 건강상의 이점이 있는 것으로 인식되고 있기 때문입니다. 회복을 촉진하는 전통 치료제를 제공함으로써 한약을 지원하고, 바이러스 감염 관리에서 한약 치료의 역할을 보여주고 있습니다. 예를 들어, 2024년 9월 HerbalGram은 허브 영양 보충제의 연간 매출이 4.4%로 성장하여 2022년 120억 1,800만 달러에서 2023년 125억 5,100만 달러로 증가할 것이라고 보고했습니다. 그 결과, 한약에 대한 수요 증가가 COVID-19용 곽향정기(Huoxiang Zhengqi) 시장 성장에 박차를 가하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

ksm
영문 목차

영문목차

Huoxiang Zhengqi for COVID-19 is a traditional Chinese herbal formula used to treat COVID-19 cases, particularly when gastrointestinal symptoms such as nausea, diarrhea, or fatigue due to dampness are present. The primary aim in this context is to expel dampness, relieve exterior syndromes, and support digestive and immune functions. It is often combined with antiviral and supportive therapies as part of traditional Chinese medicine protocols.

The primary product forms of Huoxiang Zhengqi for COVID-19 include liquid, pills, granules, and other variants. The liquid form of Huoxiang Zhengqi is a traditional herbal remedy designed to alleviate digestive issues such as nausea, vomiting, and bloating by balancing the stomach and spleen. Its typical consumers include health-conscious individuals, those seeking immune system support, alternative medicine supporters, and parents purchasing for their children. It is commonly used for preventive health, managing COVID-19 symptoms, post-recovery health management, as well as for seasonal and illness-related protection. It is suitable for use in hospitals, clinics, home care settings, and other environments, with applications across hospitals, clinics, home care, and additional settings.

The huoxiang zhengqi for COVID-19 market research report is one of a series of new reports from The Business Research Company that provides huoxiang zhengqi for COVID-19 market statistics, including the huoxiang zhengqi for COVID-19 industry's global market size, regional shares, competitors with the huoxiang zhengqi for COVID-19 market share, detailed huoxiang zhengqi for COVID-19 market segments, market trends and opportunities, and any further data you may need to thrive in the huoxiang zhengqi for COVID-19 market. This huoxiang zhengqi for COVID-19 market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The huoxiang zhengqi for COVID-19 market size has grown rapidly in recent years. It will grow from $1.38 billion in 2024 to $1.55 billion in 2025 at a compound annual growth rate (CAGR) of 12.8%. The growth during the historic period can be attributed to the increasing demand for traditional Chinese medicine, growing public awareness of natural remedies, rising cases of gastrointestinal symptoms, a higher demand for immune-boosting products, and a surge in COVID-19 cases.

The huoxiang zhengqi for COVID-19 market size is expected to see rapid growth in the next few years. It will grow to $2.48 billion in 2029 at a compound annual growth rate (CAGR) of 12.4%. The growth projected for the forecast period can be attributed to the rising popularity of immune health supplements, the growing trend of self-medication for minor health issues, an increasing demand for non-pharmaceutical interventions, greater accessibility of traditional Chinese medicine products online, and a rising demand for personalized health solutions. Key trends expected in the forecast period include technology-assisted remote diagnosis, the development of new dosage forms, the creation of synergistic formulations, integration into telehealth platforms, and alignment with hospital COVID-19 treatment guidelines.

The rising demand for traditional Chinese medicines is expected to drive the growth of the Huoxiang Zhengqi for COVID-19 market. Traditional Chinese medicine (TCM) is an ancient healing system that utilizes herbal remedies, acupuncture, massage, and dietary therapy to balance the body's energy, promote healing, and prevent illness. The increasing demand for TCM is primarily driven by growing interest in natural and holistic health approaches, as consumers seek alternative remedies. Huoxiang Zhengqi for COVID-19 enhances TCM by offering a therapeutic solution that integrates herbal ingredients known for their ability to balance the immune system and alleviate symptoms associated with viral infections. For instance, in January 2025, the National Library of Medicine reported that the export value of traditional Chinese medicine, including medicinal materials and plant extracts, reached $1.933 billion in 2023. As a result, the growing demand for traditional Chinese medicines is driving the growth of the Huoxiang Zhengqi for COVID-19 market.

The increasing demand for herbal medicine is also expected to propel the growth of the Huoxiang Zhengqi for COVID-19 market. Herbal medicine involves using plants or plant-derived substances for therapeutic purposes to prevent, treat, or manage health conditions. The rising preference for herbal medicine is mainly driven by consumers' interest in natural remedies, as they perceive these alternatives to be safer, with fewer side effects and additional health benefits compared to synthetic drugs. Huoxiang Zhengqi for COVID-19 supports herbal medicine by providing a traditional remedy that boosts immune function, alleviates symptoms, and promotes recovery, showing the role of herbal therapies in managing viral infections. For instance, in September 2024, the HerbalGram reported a 4.4% growth in annual sales of herbal dietary supplements, increasing from $12.018 billion in 2022 to $12.551 billion in 2023. Consequently, the growing demand for herbal medicine is fueling the growth of the Huoxiang Zhengqi for COVID-19 market.

The rising incidence of respiratory diseases is expected to drive further growth in the Huoxiang Zhengqi for COVID-19 market. Respiratory diseases are conditions that affect the lungs and respiratory system, often leading to breathing difficulties and impaired lung function. The rise in respiratory diseases is primarily due to increasing air pollution, which exposes individuals to harmful pollutants that irritate the airways and worsen lung health. Huoxiang Zhengqi for COVID-19 aids in treating respiratory diseases by addressing symptoms linked to dampness and digestive imbalances, which are common in respiratory infections. It supports recovery by alleviating nausea, chest congestion, and fatigue, enhancing resilience during mild respiratory illnesses. For instance, in April 2024, the Australian Bureau of Statistics reported a rise in deaths due to acute respiratory infections, with 361 deaths in 2023 compared to 241 in 2022. Thus, the increasing incidence of respiratory diseases is further fueling the growth of the Huoxiang Zhengqi for COVID-19 market.

Major players in the huoxiang zhengqi for covid 19 market are Yunnan Baiyao Group Co. Ltd., Beijing Tongrentang Co. Ltd., Taiji Group Chongqing Fuling Pharmaceutical Factory Co. Ltd, Zhangzhou Pientzehuang Pharmaceutical Co. Ltd, Tasly Pharmaceutical Group Co. Ltd., Harbin Pharmaceutical Group Co. Ltd., Guizhou Sanli Pharmaceutical Co. Ltd, China Shineway Pharmaceutical Group Limited, Hubei University of Chinese Medicine, Beijing University of Chinese Medicine, Wuhu Zhanghengchun Medicine Co. Ltd.

Asia-Pacific was the largest region in the Huoxiang Zhengqi for COVID-19 market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in huoxiang Zhengqi for COVID-19 report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the huoxiang Zhengqi for COVID-19 market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The huoxiang Zhengqi for COVID-19 market consists of sales of syrups, powders, injections, essential oils, and nasal sprays. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Huoxiang Zhengqi For Covid 19 Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on huoxiang zhengqi for covid 19 market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for huoxiang zhengqi for covid 19 ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The huoxiang zhengqi for covid 19 market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

5) By Distribution Chanel; Online Pharmacies; Retail Pharmacies; Hospital Pharmacies; Other Distribution Chanels

Table of Contents

1. Executive Summary

2. Huoxiang Zhengqi For Covid 19 Market Characteristics

3. Huoxiang Zhengqi For Covid 19 Market Trends And Strategies

4. Huoxiang Zhengqi For Covid 19 Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Huoxiang Zhengqi For Covid 19 Growth Analysis And Strategic Analysis Framework

6. Huoxiang Zhengqi For Covid 19 Market Segmentation

7. Huoxiang Zhengqi For Covid 19 Market Regional And Country Analysis

8. Asia-Pacific Huoxiang Zhengqi For Covid 19 Market

9. China Huoxiang Zhengqi For Covid 19 Market

10. India Huoxiang Zhengqi For Covid 19 Market

11. Japan Huoxiang Zhengqi For Covid 19 Market

12. Australia Huoxiang Zhengqi For Covid 19 Market

13. Indonesia Huoxiang Zhengqi For Covid 19 Market

14. South Korea Huoxiang Zhengqi For Covid 19 Market

15. Western Europe Huoxiang Zhengqi For Covid 19 Market

16. UK Huoxiang Zhengqi For Covid 19 Market

17. Germany Huoxiang Zhengqi For Covid 19 Market

18. France Huoxiang Zhengqi For Covid 19 Market

19. Italy Huoxiang Zhengqi For Covid 19 Market

20. Spain Huoxiang Zhengqi For Covid 19 Market

21. Eastern Europe Huoxiang Zhengqi For Covid 19 Market

22. Russia Huoxiang Zhengqi For Covid 19 Market

23. North America Huoxiang Zhengqi For Covid 19 Market

24. USA Huoxiang Zhengqi For Covid 19 Market

25. Canada Huoxiang Zhengqi For Covid 19 Market

26. South America Huoxiang Zhengqi For Covid 19 Market

27. Brazil Huoxiang Zhengqi For Covid 19 Market

28. Middle East Huoxiang Zhengqi For Covid 19 Market

29. Africa Huoxiang Zhengqi For Covid 19 Market

30. Huoxiang Zhengqi For Covid 19 Market Competitive Landscape And Company Profiles

31. Huoxiang Zhengqi For Covid 19 Market Other Major And Innovative Companies

32. Global Huoxiang Zhengqi For Covid 19 Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Huoxiang Zhengqi For Covid 19 Market

34. Recent Developments In The Huoxiang Zhengqi For Covid 19 Market

35. Huoxiang Zhengqi For Covid 19 Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기